The store will not work correctly when cookies are disabled.
2-acetyl-3-amino-5-methyl-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one
ID: ALA5187119
Chembl Id: CHEMBL5187119
PubChem CID: 168278908
Max Phase: Preclinical
Molecular Formula: C9H12N4O2
Molecular Weight: 208.22
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)n1nc2c(c1N)CC(C)C(=O)N2
Standard InChI: InChI=1S/C9H12N4O2/c1-4-3-6-7(10)13(5(2)14)12-8(6)11-9(4)15/h4H,3,10H2,1-2H3,(H,11,12,15)
Standard InChI Key: XESABZGPUVPKGS-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 208.22 | Molecular Weight (Monoisotopic): 208.0960 | AlogP: 0.26 | #Rotatable Bonds: ┄ |
Polar Surface Area: 90.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.13 | CX Basic pKa: ┄ | CX LogP: 0.19 | CX LogD: 0.19 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.64 | Np Likeness Score: -0.22 |
References
1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S.. (2022) Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor., 65 (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941] |